Skip to content
Acceleron Pharma

Investors/Media

Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Sep 20, 2007
Cambridge, Mass. – September 20, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John Knopf, Ph.D., Chief Executive Officer of Acceleron, will provide a corporate presentation at the UBS 2007 Global ...
Sep 20, 2007
Cambridge, Mass. – September 20, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that ACE-011 improved bone microarchitecture, increased bone mineral density and bone mechanical strength. The result...
Sep 18, 2007
Honolulu, HI – September 18, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced positive results for the phase 1 clinical trial of ACE-011 at The American Society for Bone and Mineral Research (ASBMR) ...
Sep 18, 2007
Cambridge, MA – September 18, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that John L. Knopf, Ph.D., has been named as the Chief Executive Officer of Acceleron. Dr. Knopf has also been elected t...
Aug 6, 2007
CAMBRIDGE, MA – August 6, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced it will present the final results for the phase 1 clinical trial of ACE-011, its novel anabolic therapy for the treatment of...
Aug 1, 2007
Pharmaceutical Executive, August 1, 2007
Jul 31, 2007
CAMBRIDGE, MA – July 31, 2007 - Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that company President and Founder, John Knopf, Ph.D., will provide a corporate presentation at the 27th Annual Canaccord Adams Global Growth Conference on Tuesday August 7, 2007 at 1:30 pm ...
Jul 16, 2007
Link to article
Jun 26, 2007
Kos, Greece – June 26, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced results demonstrating that ACE-011, a novel anabolic bone agent for the treatment of bone loss, preserved bone mass and...
Jun 1, 2007
Start-Up: June 1, 2007
May 14, 2007
LUCCA, ITALY – May 14, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced results of a preclinical study with ACE-031 that demonstrated the ability of the compound to increase muscle mass and s...
Apr 25, 2007
CAMBRIDGE, MA – April 25, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of James Desiderio, Ph.D. as Vice President, Program Management.. “The Acceleron pro...
Apr 1, 2007
Link to article
Mar 29, 2007
CAMBRIDGE, MA – March 29, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing therapeutics for the treatment of musculoskeletal, metabolic and cancer-related diseases, today announced the appointment of Robert Steininger as Senior Vice President, Manufacturing. “Acceleron is rapidly advancing and ...
Mar 7, 2007
CAMBRIDGE, MA – March 7, 2007 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel biotherapeutics, today announced that Steven Ertel, Vice President Business Development, will provide a corporate presentation at the Cowen and Company 27th Annual Health Care Conference on Thursday March 15, 2007 at 9:30...
= add release to Briefcase